首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Knockdown of ANGPTL-4 inhibits inflammatory response and extracellular matrix accumulation in glomerular mesangial cells cultured under high glucose condition
【24h】

Knockdown of ANGPTL-4 inhibits inflammatory response and extracellular matrix accumulation in glomerular mesangial cells cultured under high glucose condition

机译:敲低ANGPTL-4抑制高糖条件下培养的肾小球系膜细胞的炎症反应和细胞外基质积累

获取原文
           

摘要

Diabetic nephropathy (DN) is one of the major diabetic complications that lead to end-stage renal failure. Angiopoietin-like protein-4 (ANGPTL-4) has been reported to be dysregulated in diabetes mellitus and diabetic complications. However, the role of ANGPTL-4 in glomerular mesangial cells (MCs) during DN remains unclear. In the present study, we evaluated the role of ANGPTL-4 in MCs in response to high glucose (HG) condition and the potential mechanism. The results proved that ANGPTL-4 expression is significantly increased in HG-stimulated MCs. Knockdown of ANGPTL-4 suppressed HG-induced cell proliferation of MCs. The production of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6 were decreased in ANGPTL-4 knocked down MCs. Inhibition of ANGPTL-4 markedly suppressed the expressions of extracellular matrix (ECM) proteins, collagen IV (Col IV) and fibronectin (FN), in HG-stimulated MCs. Furthermore, ANGPTL-4 knockdown inhibited the HG-induced activation of NF-κB signaling pathway in MCs. Collectively, knockdown of ANGPTL-4 suppressed HG-induced cell proliferation, inflammatory response, and ECM accumulation inhibiting NF-κB signaling pathway in MCs. These findings suggested that ANGPTL-4 might be a therapeutic target for the prevention and treatment of DN.
机译:糖尿病肾病(DN)是导致终末期肾衰竭的主要糖尿病并发症之一。据报道,血管生成素样蛋白4(ANGPTL-4)在糖尿病和糖尿病并发症中失调。然而,尚不清楚DNP期间ANGPTL-4在肾小球系膜细胞(MCs)中的作用。在本研究中,我们评估了ANGPTL-4在MC中对高血糖(HG)病情反应的作用及其潜在机制。结果证明,在HG刺激的MC中ANGPTL-4表达显着增加。敲低ANGPTL-4抑制了HG诱导的MC的细胞增殖。在ANGPTL-4敲除的MC中,促炎细胞因子包括TNF-α,IL-1β,IL-6的产生减少。抑制ANGPTL-4可显着抑制HG刺激的MC中细胞外基质(ECM)蛋白,胶原IV(Col IV)和纤连蛋白(FN)的表达。此外,ANGPTL-4敲低抑制了MCs中HG诱导的NF-κB信号通路的激活。总的来说,ANGPTL-4的抑制可抑制HG诱导的细胞增殖,炎症反应以及ECM积聚抑制MC中的NF-κB信号通路。这些发现表明ANGPTL-4可能是预防和治疗DN的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号